Medical - Devices
Compare Stocks
4 / 10Stock Comparison
ESTA vs AEYE vs ALGN vs ALKT
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Application
Medical - Devices
Software - Application
ESTA vs AEYE vs ALGN vs ALKT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Medical - Devices | Software - Application | Medical - Devices | Software - Application |
| Market Cap | $2.12B | $100M | $12.06B | $1.87B |
| Revenue (TTM) | $211M | $40M | $4.10B | $472M |
| Net Income (TTM) | $-51M | $-3M | $430M | $-50M |
| Gross Margin | 69.3% | 78.3% | 67.7% | 57.4% |
| Operating Margin | -18.5% | -7.9% | 14.4% | -9.3% |
| Forward P/E | — | — | 14.8x | 23.0x |
| Total Debt | $264M | $721K | $114M | $354M |
| Cash & Equiv. | $76M | $5M | $1.08B | $63M |
ESTA vs AEYE vs ALGN vs ALKT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Apr 21 | May 26 | Return |
|---|---|---|---|
| Establishment Labs … (ESTA) | 100 | 98.8 | -1.2% |
| AudioEye, Inc. (AEYE) | 100 | 31.1 | -68.9% |
| Align Technology, I… (ALGN) | 100 | 28.3 | -71.7% |
| Alkami Technology, … (ALKT) | 100 | 37.7 | -62.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ESTA vs AEYE vs ALGN vs ALKT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ESTA is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 27.1%, EPS growth 42.7%, 3Y rev CAGR 9.3%
- 191.0% 10Y total return vs ALGN's 122.8%
- +116.5% vs ALKT's -37.8%
AEYE lags the leaders in this set but could rank higher in a more targeted comparison.
ALGN carries the broadest edge in this set and is the clearest fit for value and quality.
- Lower P/E (14.8x vs 23.0x)
- 10.5% margin vs ESTA's -24.2%
- 6.9% ROA vs ESTA's -15.0%, ROIC 15.4% vs -14.6%
ALKT is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 1 yrs, beta 1.30
- Lower volatility, beta 1.30, Low D/E 97.7%, current ratio 2.09x
- Beta 1.30, current ratio 2.09x
- 32.9% revenue growth vs ALGN's 0.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 32.9% revenue growth vs ALGN's 0.9% | |
| Value | Lower P/E (14.8x vs 23.0x) | |
| Quality / Margins | 10.5% margin vs ESTA's -24.2% | |
| Stability / Safety | Beta 1.30 vs AEYE's 2.29 | |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | +116.5% vs ALKT's -37.8% | |
| Efficiency (ROA) | 6.9% ROA vs ESTA's -15.0%, ROIC 15.4% vs -14.6% |
ESTA vs AEYE vs ALGN vs ALKT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
ESTA vs AEYE vs ALGN vs ALKT — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ALGN leads in 3 of 6 categories
ESTA leads 1 • AEYE leads 0 • ALKT leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ALGN leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ALGN is the larger business by revenue, generating $4.1B annually — 101.6x AEYE's $40M. ALGN is the more profitable business, keeping 10.5% of every revenue dollar as net income compared to ESTA's -24.2%. On growth, ESTA holds the edge at +45.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $211M | $40M | $4.1B | $472M |
| EBITDAEarnings before interest/tax | -$32M | -$504,000 | $790M | -$12M |
| Net IncomeAfter-tax profit | -$51M | -$3M | $430M | -$50M |
| Free Cash FlowCash after capex | -$57M | $2M | $717M | $44M |
| Gross MarginGross profit ÷ Revenue | +69.3% | +78.3% | +67.7% | +57.4% |
| Operating MarginEBIT ÷ Revenue | -18.5% | -7.9% | +14.4% | -9.3% |
| Net MarginNet income ÷ Revenue | -24.2% | -7.6% | +10.5% | -10.6% |
| FCF MarginFCF ÷ Revenue | -27.2% | +5.5% | +17.5% | +9.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +45.2% | +7.9% | +6.2% | +28.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +92.6% | +29.0% | +23.6% | -22.7% |
Valuation Metrics
ALGN leads this category, winning 3 of 5 comparable metrics.
Valuation Metrics
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $2.1B | $100M | $12.1B | $1.9B |
| Enterprise ValueMkt cap + debt − cash | $2.3B | $96M | $11.1B | $2.2B |
| Trailing P/EPrice ÷ TTM EPS | -41.88x | -32.36x | 29.80x | -37.89x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 14.84x | 22.99x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | — | 13.92x | — |
| Price / SalesMarket cap ÷ Revenue | 10.03x | 2.49x | 2.99x | 4.20x |
| Price / BookPrice ÷ Book value/share | 90.61x | 20.91x | 3.02x | 5.00x |
| Price / FCFMarket cap ÷ FCF | — | — | 24.57x | 45.09x |
Profitability & Efficiency
ALGN leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
ALGN delivers a 10.7% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-2 for ESTA. ALGN carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to ESTA's 11.23x. On the Piotroski fundamental quality scale (0–9), ALGN scores 7/9 vs ALKT's 3/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -2.0% | -47.8% | +10.7% | -14.0% |
| ROA (TTM)Return on assets | -15.0% | -9.5% | +6.9% | -5.9% |
| ROICReturn on invested capital | -14.6% | -42.4% | +15.4% | -8.6% |
| ROCEReturn on capital employed | -14.1% | -17.7% | +14.5% | -9.3% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 4 | 7 | 3 |
| Debt / EquityFinancial leverage | 11.23x | 0.15x | 0.03x | 0.98x |
| Net DebtTotal debt minus cash | $189M | -$5M | -$965M | $290M |
| Cash & Equiv.Liquid assets | $76M | $5M | $1.1B | $63M |
| Total DebtShort + long-term debt | $264M | $721,000 | $114M | $354M |
| Interest CoverageEBIT ÷ Interest expense | -1.30x | -2.79x | 389.13x | -3.73x |
Total Returns (Dividends Reinvested)
ESTA leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ESTA five years ago would be worth $10,061 today (with dividends reinvested), compared to $2,814 for ALGN. Over the past 12 months, ESTA leads with a +116.5% total return vs ALKT's -37.8%. The 3-year compound annual growth rate (CAGR) favors ALKT at 12.2% vs ALGN's -18.1% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +4.6% | -18.7% | +7.9% | -23.1% |
| 1-Year ReturnPast 12 months | +116.5% | -27.9% | -2.2% | -37.8% |
| 3-Year ReturnCumulative with dividends | +6.4% | +20.6% | -45.0% | +41.1% |
| 5-Year ReturnCumulative with dividends | +0.6% | -60.2% | -71.9% | -54.9% |
| 10-Year ReturnCumulative with dividends | +191.0% | +102.2% | +122.8% | -59.5% |
| CAGR (3Y)Annualised 3-year return | +2.1% | +6.4% | -18.1% | +12.2% |
Risk & Volatility
Evenly matched — ESTA and ALKT each lead in 1 of 2 comparable metrics.
Risk & Volatility
ALKT is the less volatile stock with a 1.30 beta — it tends to amplify market swings less than AEYE's 2.29 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ESTA currently trades 86.5% from its 52-week high vs AEYE's 49.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.27x | 2.18x | 1.65x | 1.23x |
| 52-Week HighHighest price in past year | $83.31 | $16.39 | $208.31 | $31.66 |
| 52-Week LowLowest price in past year | $32.75 | $5.31 | $122.00 | $14.11 |
| % of 52W HighCurrent price vs 52-week peak | +86.5% | +49.4% | +80.8% | +55.1% |
| RSI (14)Momentum oscillator 0–100 | 66.8 | 61.3 | 44.6 | 50.9 |
| Avg Volume (50D)Average daily shares traded | 455K | 194K | 1.1M | 1.9M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: ESTA as "Buy", ALGN as "Buy", ALKT as "Buy". Consensus price targets imply 26.2% upside for ALKT (target: $22) vs 18.0% for ESTA (target: $85).
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | — | Buy | Buy |
| Price TargetConsensus 12-month target | $85.00 | — | $203.60 | $22.00 |
| # AnalystsCovering analysts | 14 | — | 33 | 12 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | 1 | — | 1 |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +3.9% | 0.0% |
ALGN leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). ESTA leads in 1 (Total Returns). 1 tied.
ESTA vs AEYE vs ALGN vs ALKT: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ESTA or AEYE or ALGN or ALKT a better buy right now?
For growth investors, Alkami Technology, Inc.
(ALKT) is the stronger pick with 32. 9% revenue growth year-over-year, versus 0. 9% for Align Technology, Inc. (ALGN). Align Technology, Inc. (ALGN) offers the better valuation at 29. 8x trailing P/E (14. 8x forward), making it the more compelling value choice. Analysts rate Establishment Labs Holdings Inc. (ESTA) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ESTA or AEYE or ALGN or ALKT?
On forward P/E, Align Technology, Inc.
is actually cheaper at 14. 8x.
03Which is the better long-term investment — ESTA or AEYE or ALGN or ALKT?
Over the past 5 years, Establishment Labs Holdings Inc.
(ESTA) delivered a total return of +0. 6%, compared to -71. 9% for Align Technology, Inc. (ALGN). Over 10 years, the gap is even starker: ESTA returned +190. 0% versus ALKT's -58. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ESTA or AEYE or ALGN or ALKT?
By beta (market sensitivity over 5 years), Alkami Technology, Inc.
(ALKT) is the lower-risk stock at 1. 23β versus AudioEye, Inc. 's 2. 18β — meaning AEYE is approximately 77% more volatile than ALKT relative to the S&P 500. On balance sheet safety, Align Technology, Inc. (ALGN) carries a lower debt/equity ratio of 3% versus 11% for Establishment Labs Holdings Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — ESTA or AEYE or ALGN or ALKT?
By revenue growth (latest reported year), Alkami Technology, Inc.
(ALKT) is pulling ahead at 32. 9% versus 0. 9% for Align Technology, Inc. (ALGN). On earnings-per-share growth, the picture is similar: Establishment Labs Holdings Inc. grew EPS 42. 7% year-over-year, compared to -12. 2% for Alkami Technology, Inc.. Over a 3-year CAGR, ALKT leads at 29. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ESTA or AEYE or ALGN or ALKT?
Align Technology, Inc.
(ALGN) is the more profitable company, earning 10. 2% net margin versus -24. 2% for Establishment Labs Holdings Inc. — meaning it keeps 10. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALGN leads at 15. 3% versus -18. 5% for ESTA. At the gross margin level — before operating expenses — AEYE leads at 78. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ESTA or AEYE or ALGN or ALKT more undervalued right now?
On forward earnings alone, Align Technology, Inc.
(ALGN) trades at 14. 8x forward P/E versus 23. 0x for Alkami Technology, Inc. — 8. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ALKT: 26. 2% to $22. 00.
08Which pays a better dividend — ESTA or AEYE or ALGN or ALKT?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is ESTA or AEYE or ALGN or ALKT better for a retirement portfolio?
For long-horizon retirement investors, Establishment Labs Holdings Inc.
(ESTA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 27), +190. 0% 10Y return). AudioEye, Inc. (AEYE) carries a higher beta of 2. 18 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ESTA: +190. 0%, AEYE: +96. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ESTA and AEYE and ALGN and ALKT?
These companies operate in different sectors (ESTA (Healthcare) and AEYE (Technology) and ALGN (Healthcare) and ALKT (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: ESTA is a small-cap high-growth stock; AEYE is a small-cap quality compounder stock; ALGN is a mid-cap quality compounder stock; ALKT is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.